StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Veracyte, Inc.
NasdaqGM:VCYT
Sector
Location
Market Cap
USD 1.85 B
Share Price
USD 23.59
Avg Daily Volume
1,028,606
Change (1 day)
-2.56%
Change (1 year)
0.73%
Change (YTD)
-40.43%
Veracyte, Inc. Shareholders' Equity for the year ending December 31, 2024: USD 1.18 B
Veracyte, Inc. Shareholders' Equity is USD 1.18 B for the year ending December 31, 2024, a 12.63% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Veracyte, Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 1.04 B, a -2.89% change year over year.
-
Veracyte, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 1.08 B, a -1.94% change year over year.
-
Veracyte, Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 1.10 B, a 160.31% change year over year.
-
Veracyte, Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 421.23 M, a 75.91% change year over year.
Competitors
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Tempus AI, Inc.
USD 63.34
TEM
-1.52
-2.34%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Medtronic plc
USD 92.32
MDT
+0.31
0.34%
RELX Plc
USD 53.64
REL.L
+0.75
1.42%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Becton, Dickinson and Company
USD 183.63
BDX
+1.05
0.57%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
IDEXX Laboratories, Inc.
USD 549.97
IDXX
+9.29
1.72%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
Agilent Technologies, Inc.
USD 120.35
A
+0.88
0.74%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Waters Corporation
USD 298.47
WAT
+2.84
0.96%
bioMérieux S.A.
USD 147.51
BIM.PA
+3.95
2.76%
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
West Pharmaceutical Services, Inc.
USD 279.10
WST
+51.79
22.78%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Tempus AI, Inc.
USD 63.34
TEM
-1.52
-2.34%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Medtronic plc
USD 92.32
MDT
+0.31
0.34%
RELX Plc
USD 53.64
REL.L
+0.75
1.42%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Becton, Dickinson and Company
USD 183.63
BDX
+1.05
0.57%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
IDEXX Laboratories, Inc.
USD 549.97
IDXX
+9.29
1.72%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
Agilent Technologies, Inc.
USD 120.35
A
+0.88
0.74%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Waters Corporation
USD 298.47
WAT
+2.84
0.96%
bioMérieux S.A.
USD 147.51
BIM.PA
+3.95
2.76%
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
West Pharmaceutical Services, Inc.
USD 279.10
WST
+51.79
22.78%